Ever Source Wealth Advisors, LLC Atea Pharmaceuticals, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 93,927 shares of AVIR stock, worth $293,052. This represents 0.02% of its overall portfolio holdings.
Number of Shares
93,927
Previous 116
80871.55%
Holding current value
$293,052
Previous $0
Infinity%
% of portfolio
0.02%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AVIR
# of Institutions
110Shares Held
48.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY9.12MShares$28.5 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$23.7 Million20.73% of portfolio
-
Tang Capital Management LLC San Diego, CA4.89MShares$15.3 Million1.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$15.2 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$7.76 Million2.68% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $260M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...